Healthcare Triangle signs advance agreement for $50M acquisition of AI CX business with $34M revenue target

Healthcare Triangle, Inc.

Total consideration up to $50M: $15M cash, $6M common stock, $24M convertible preferred, $5M earnout.
Advance of $3M cash paid to Teyame; refundable if deal fails; target closing by Feb 16, 2026.
Target companies expected to generate $34M revenue and $4.2M EBITDA for FY2025.
Acquisition would combine HCTI's healthcare IT with AI omnichannel CX platforms.
Deal is non-binding and subject to definitive agreement, due diligence, and shareholder approval.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.